Jim Wassil - 06 Jun 2023 Form 4 Insider Report for Icosavax, Inc.

Role
Director
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact for Jim Wassil
Issuer symbol
N/A
Transactions as of
06 Jun 2023
Net transactions value
$0
Form type
4
Filing time
08 Jun 2023, 16:45:59 UTC
Previous filing
03 Mar 2023
Next filing
06 Sep 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Award $0 +17,000 $0.000000 17,000 06 Jun 2023 Common Stock 17,000 $9.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12th of the total number of shares of common stock subject to the option vest monthly following June 6, 2023, the vesting commencement date, provided if the next occurring annual meeting of the Issuer's stockholders occurs prior to the full vesting of the option, any remaining options will vest on the date of such annual meeting, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date.